rxstat › Shortages › Recombinant Human Papillomavirus Type 6 L1 Protein Recombinant Human Papillomavirus Type 11 L1 Protein Recombinant Human Papillomavirus Type 16 L1 Protein Recombinant Human Papillomavirus Type 18 L1 Protein

Recombinant Human Papillomavirus Type 6 L1 Protein Recombinant Human Papillomavirus Type 11 L1 Protein Recombinant Human Papillomavirus Type 16 L1 Protein Recombinant Human Papillomavirus Type 18 L1 Protein shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Recombinant Human Papillomavirus Type 6 L1 Protein Recombinant Human Papillomavirus Type 11 L1 Protein Recombinant Human Papillomavirus Type 16 L1 Protein Recombinant Human Papillomavirus Type 18 L1 Protein products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 1
Reports on file
2

Reports by product

Discontinued
GARDASIL
20MCG 40MCG 40MCG 20MCG · SUSPENSION · MERCK CANADA INC
DIN 02283190
Discontinued
GARDASIL
20MCG 40MCG 40MCG 20MCG · SUSPENSION · MERCK CANADA INC
DIN 02283190

What's happening

One or more Recombinant Human Papillomavirus Type 6 L1 Protein Recombinant Human Papillomavirus Type 11 L1 Protein Recombinant Human Papillomavirus Type 16 L1 Protein Recombinant Human Papillomavirus Type 18 L1 Protein products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Recombinant Human Papillomavirus Type 6 L1 Protein Recombinant Human Papillomavirus Type 11 L1 Protein Recombinant Human Papillomavirus Type 16 L1 Protein Recombinant Human Papillomavirus Type 18 L1 Protein is classified under “VIRAL VACCINES” (ATC J07BM).

Recent changes

Common questions

When will Recombinant Human Papillomavirus Type 6 L1 Protein Recombinant Human Papillomavirus Type 11 L1 Protein Recombinant Human Papillomavirus Type 16 L1 Protein Recombinant Human Papillomavirus Type 18 L1 Protein be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Recombinant Human Papillomavirus Type 6 L1 Protein Recombinant Human Papillomavirus Type 11 L1 Protein Recombinant Human Papillomavirus Type 16 L1 Protein Recombinant Human Papillomavirus Type 18 L1 Protein in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (viral vaccines)

Partial shortageHepatitis B Surface Antigen1 of 8 reported products affected · est. return Aug 10, 2026Partial shortageHepatitis B Surface Antigen Hepatitis A Virus / Inactivated1 of 2 reported products affected · est. return Jun 15, 2026No current shortage*sarscov2 S-protein Mrna / 5'[m27 / 3'-ogpppNo current shortageChikungunya Virus Live-attenuatedNo current shortageHaemagglutinin-strain A Haemagglutinin-strain A Haemagglutinin-strain B Haemagglutinin-strain BNo current shortageHepatitis A Virus / Inactivated

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.